Results 41 to 50 of about 1,511 (168)
Ocular hypotensive effect of fixed-combination brinzolamide/brimonidine adjunctive to a prostaglandin analog: a randomized clinical trial [PDF]
, 2016 To determine whether intraocular pressure (IOP) lowering with fixed-combination brinzolamide/brimonidine (BBFC) adjunctive to a prostaglandin analog (PGA) was superior to that of vehicle+PGA in patients with open-angle glaucoma or ocular hypertension who
Budenz, +4 more
core +2 more sources
International Journal of Ophthalmology, 2012 AIM: To evaluate the short-term effect of the fixed combination of brinzolamide-timolol on the ocular surface in glaucoma patients.METHODS: This is a prospective study of 23 eyes of 23 patients with newly diagnosed glaucoma.
Penpe Gul Firat +5 more
doaj +1 more source
International Journal of Ophthalmology, 2013 AIM: To evaluate the effect of brinzolamide-timolol fixed combination on intraocular pressure (IOP) after cataract surgery.METHODS:The study included 92 eyes of 87 patients who underwent cataract surgery and intraocular lens implantation.
Kemal Örnek +5 more
doaj +1 more source
Carbonic anhydrase inhibitors in the management of macular edema: A review of the literature [PDF]
, 2022 Background: Macular edema (ME) is a vision-threatening condition that commonly develops as a consequence of ocular diseases, including age-related macular degeneration, retinal vaso-occlusion of the central retinal vein and its branches, diabetic ...
Shahsuvaryan, Marianne L
core +2 more sources
Otolaryngology–Head and Neck Surgery, EarlyView.Abstract Objective This study aims to characterize diuretic use among patients with and without benign paroxysmal positional vertigo (BPPV) using a population‐level database. Study Design A case‐control study. Setting TriNetX US Collaborative Network. Methods Subjects with ≥1 hospital visit between 2019 and 2024 were queried and stratified by age (18 ...
Marwin Li +2 more
wiley +1 more source
Carbonic Anhydrase Inhibitors in the Treatment of Glaucoma. Review. Part I
Oftalʹmologiâ, 2020 Glaucoma is the main cause of irreversible blindness in the world. Carbonic anhydrase inhibitors (CAIS) used both systemically and topically, reduce intraocular pressure effectively.
N. I. Kurysheva
doaj +1 more source
Ophthalmology and Therapy, 2023 Introduction The factors related to the ocular penetration of drugs after the administration of eye drops in humans have not been examined in detail. Therefore, this study assessed the influence of patient factors on the intraocular penetration of eye ...
Eriko Kunikane +3 more
doaj +1 more source
Acta Ophthalmologica, EarlyView.Abstract Purpose To investigate the incidence and risk factors of retinal detachment (RD) and bacterial endophthalmitis in a cohort of children who underwent cataract surgery before the age of eight. Methods Data was retrieved from the Swedish national paediatric cataract register.
Arzu Seyhan Karatepe Hashas +8 more
wiley +1 more source
Visual field testing and glaucoma drug prescribing patterns in Australia
Ophthalmic and Physiological Optics, EarlyView.Abstract Purpose To examine glaucoma practice patterns in Australia, focusing on visual field test uptake and antiglaucoma drug prescribing by optometrists and ophthalmologists. Design A serial cross‐sectional study was conducted to describe visual field testing charges and compare them to changes in comprehensive eye examination charges, as well as to
Catherine L. Jan +8 more
wiley +1 more source
Drug Delivery, 2020 Co-delivery nanoparticles with characteristics of intracellular precision release drug have been generally accepted as an effective therapeutic strategy for eye diseases.
Tingting Li +6 more
doaj +1 more source